107 related articles for article (PubMed ID: 36503726)
21. Insurance status impacts treatment for hepatocellular carcinoma.
Sobotka LA; Hinton A; Conteh LF
Ann Hepatol; 2019; 18(3):461-465. PubMed ID: 31040093
[TBL] [Abstract][Full Text] [Related]
22. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
[TBL] [Abstract][Full Text] [Related]
23. Disparities in Hepatocellular Carcinoma Survival by Insurance Status: A Population-Based Study in China.
Wu J; Liu C; Wang F
Front Public Health; 2021; 9():742355. PubMed ID: 34805067
[No Abstract] [Full Text] [Related]
24. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
Gutin L; Yao F; Dodge JL; Grab J; Mehta N
JAMA Netw Open; 2019 Aug; 2(8):e1910326. PubMed ID: 31469395
[TBL] [Abstract][Full Text] [Related]
25. Medicare/Medicaid Insurance, Rurality, and Black Race Associated With Provision of Hepatocellular Carcinoma Treatment and Survival.
Moon AM; Sanoff HK; Chang Y; Lund JL; Barritt AS; Hayashi PH; Stitzenberg KB
J Natl Compr Canc Netw; 2021 Feb; 19(3):285-293. PubMed ID: 33578376
[TBL] [Abstract][Full Text] [Related]
26. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
[TBL] [Abstract][Full Text] [Related]
27. Treatment at Academic Centers Decreases Insurance-Based Survival Disparities in Colon Cancer.
Cabo J; Shu X; Shu XO; Parikh A; Bailey C
J Surg Res; 2020 Jan; 245():265-272. PubMed ID: 31421372
[TBL] [Abstract][Full Text] [Related]
28. Disparities in outcomes and access to therapy options in hepatocellular carcinoma.
Beltrán Ponce S; Gokun Y; Douglass F; Dawson L; Miller E; Thomas CR; Pitter K; Conteh L; Diaz DA
J Natl Cancer Inst; 2024 Feb; 116(2):264-274. PubMed ID: 37831897
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
Jones PD; Diaz C; Wang D; Gonzalez-Diaz J; Martin P; Kobetz E
Dig Dis Sci; 2018 Feb; 63(2):515-528. PubMed ID: 29275448
[TBL] [Abstract][Full Text] [Related]
30. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
31. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
32. Effect of marital status on the survival of patients with hepatocellular carcinoma treated with surgical resection: an analysis of 13,408 patients in the surveillance, epidemiology, and end results (SEER) database.
Wu C; Chen P; Qian JJ; Jin SJ; Yao J; Wang XD; Bai DS; Jiang GQ
Oncotarget; 2016 Nov; 7(48):79442-79452. PubMed ID: 27769053
[TBL] [Abstract][Full Text] [Related]
33. Sociodemographic Characteristics as Predictors of Outcomes in Hepatocellular Carcinoma: A Retrospective Cohort Study.
Beutler BD; Ulanja MB; Krishan R; Aluru V; Ndukwu ML; Hagen MM; Dupin ZD; Willyard CE; Moody AE; Boampong-Konam K; Zell SC
Cancer Control; 2020; 27(1):1073274820956615. PubMed ID: 32951450
[TBL] [Abstract][Full Text] [Related]
34. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
35. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
[TBL] [Abstract][Full Text] [Related]
36. Cancer outcomes in low-income elders: is there an advantage to being on Medicaid?
Koroukian SM; Bakaki PM; Owusu C; Earle CC; Cooper GS
Medicare Medicaid Res Rev; 2012; 2(2):. PubMed ID: 24800139
[TBL] [Abstract][Full Text] [Related]
37. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
38. Older Patients With Hepatocellular Carcinoma Have More Advanced Disease, Lower Rates of Treatment, and Lower Survival.
Yan M; Ha J; Aguilar M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2017 Apr; 51(4):378-383. PubMed ID: 27380460
[TBL] [Abstract][Full Text] [Related]
39. Treatment choices and outcomes of non-metastatic hepatocellular carcinoma patients in relationship to neighborhood socioeconomic status: a population-based study.
Abdel-Rahman O
Int J Clin Oncol; 2020 May; 25(5):861-866. PubMed ID: 31953780
[TBL] [Abstract][Full Text] [Related]
40. Does marital status impact postoperative survival in patients with less differentiated hepatocellular carcinoma? A population-based study.
Yan B; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
Cancer Med; 2019 Oct; 8(14):6272-6279. PubMed ID: 31476109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
